
Intuitive receives CE mark for da Vinci 5 cardiac procedures
Intuitive (NASDAQ: ISRG) continues to get back to its roots, claiming a European approval for its da Vinci 5 system in minimally invasive cardiac procedures.

Intuitive (NASDAQ: ISRG) continues to get back to its roots, claiming a European approval for its da Vinci 5 system in minimally invasive cardiac procedures.

In a study published in Cancer Discovery, cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells.

Researchers at the Fraunhofer Institute for Integrated Circuits IIS and the Technical University of Dresden have tested a new approach for investigating disease-related changes in body odor. Using laser-based photoacoustic spectroscopy, they analyzed volatile organic compounds in simple body swabs. An initial study revealed differences between samples from healthy individuals and those from people with Parkinson’s disease, COVID-19, and other diseases. The results, published in Scientific Reports, demonstrate the method’s potential for faster preliminary screenings in the future.

Rutgers engineers have developed a smart shoe that automatically analyzes how a person walks, a technology that someday could help monitor people with Parkinson’s disease, spinal cord injuries, traumatic brain injuries and other movement disorders. The prototype analyzes movement with 95.4% accuracy while counting steps and estimating calories burned.

SEOUL, South Korea, Sept. 29, 2026 /PRNewswire/ — Yuyu Teijin Medicare, a home healthcare joint venture between Yuyu Pharma of Korea and Teijin Pharma of Japan, has completed a pilot delivery of medical supplies by drone to a ventilator patient living on a remote Korean island.

Mobile platform combines smartphone technology, a proprietary light-occluding headset, and AI-assisted software to capture and analyze nystagmus without complex equipment.

New electronic skin combines sensing and visualisation in a single device, enabling high-resolution mapping of touch for healthcare and robotics applications

DALLAS, Sept. 28, 2026 /PRNewswire/ — Insera Therapeutics, Inc., a medical device company focused on advancing cyclical aspiration for mechanical thrombectomy, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CLEAR™ Aspiration System.

With a lot of ingenuity, some creative engineering and a few off-the-shelf items, a University of Florida team led by a virologist and an engineer has created an inexpensive, quick and accurate handheld device that can detect seven mosquito-borne illnesses

One of the main reasons ovarian cancer is among the deadliest forms of cancer is timing: When doctors catch it early, the five-year survival rate can be more than 90%. But when doctors catch it late, in stages 3 or 4, five-year survival is less than half that.